Agilent Technologies, Inc. $A Shares Acquired by Parnassus Investments LLC

Parnassus Investments LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 26.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 580,939 shares of the medical research company’s stock after buying an additional 120,483 shares during the quarter. Parnassus Investments LLC’s holdings in Agilent Technologies were worth $79,048,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Brighton Jones LLC raised its stake in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares in the last quarter. Jones Financial Companies Lllp raised its stake in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after buying an additional 769 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after buying an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its stake in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Agilent Technologies during the second quarter valued at approximately $273,000.

Agilent Technologies Stock Down 1.7%

NYSE:A opened at $129.37 on Friday. The firm has a market capitalization of $36.54 billion, a PE ratio of 25.98, a price-to-earnings-growth ratio of 2.34 and a beta of 1.26. The stock has a 50 day moving average of $119.94 and a 200-day moving average of $127.85. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.99 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is 20.48%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on A. UBS Group cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and cut their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Piper Sandler began coverage on Agilent Technologies in a research note on Thursday. They set a “neutral” rating and a $150.00 price objective on the stock. Robert W. Baird upped their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Finally, Barclays upped their target price on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $160.93.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.